Round Rock Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Buy |
+6,140
| New | +$509K | 0.09% | 135 |
|
|
2024
Q1 | – | Sell |
-2,564
| Closed | -$229K | – | 196 |
|
|
2023
Q4 | $229K | Buy |
+2,564
| New | +$229K | 0.06% | 169 |
|
|
2023
Q3 | – | Sell |
-2,958
| Closed | -$246K | – | 147 |
|
|
2023
Q2 | $246K | Sell |
2,958
-3,883
| -57% | -$323K | 0.09% | 126 |
|
|
2023
Q1 | $521K | Sell |
6,841
-184
| -3% | -$14K | 0.2% | 86 |
|
|
2022
Q4 | $583K | Buy |
7,025
+428
| +6% | +$35.5K | 0.24% | 76 |
|
|
2022
Q3 | $523K | Buy |
6,597
+1,604
| +32% | +$127K | 0.24% | 75 |
|
|
2022
Q2 | $371K | Buy |
4,993
+2,410
| +93% | +$179K | 0.17% | 90 |
|
|
2022
Q1 | $232K | Sell |
2,583
-267
| -9% | -$24K | 0.09% | 125 |
|
|
2021
Q4 | $319K | Buy |
+2,850
| New | +$319K | 0.14% | 92 |
|
|
2021
Q3 | – | Sell |
-2,047
| Closed | -$277K | – | 69 |
|
|
2021
Q2 | $277K | Sell |
2,047
-910
| -31% | -$123K | 0.2% | 53 |
|
|
2021
Q1 | $401K | Buy |
2,957
+1,284
| +77% | +$174K | 0.32% | 37 |
|
|
2020
Q4 | $235K | Buy |
+1,673
| New | +$235K | 0.22% | 46 |
|